Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/70652
Title: Digoxin and prognosis of heart failure in older patients with preserved ejection fraction: Importance of heart rate. Results from an observational and multicenter study
Authors: Llàcer, Pau
Núñez, Julio
Bayés-Genís, Antoni
Conde Martel, Alicia 
Cabanes Hernández, Yolanda
Díez Manglano, Jesús
Álvarez Rocha, Pablo
Soler Rangel, Llanos
Gómez Del Olmo, Vicente
Manzano, Luis
Montero Pérez-Barquero, Manuel
UNESCO Clasification: 3205 Medicina interna
Keywords: Digoxin
Heart failure
Prognosis
Issue Date: 2019
Journal: European Journal of Internal Medicine 
Abstract: Background: The value of digoxin in heart failure (HF) remains controversial, particularly in patients with preserved ejection fraction (HFpEF). This study evaluated the 1-year risk of events after digoxin treatment for acute heart failure (AHF) in patients >70 years old with HFpEF. Methods: 1833 patients were included in this analysis (mean age, 82 years). The main endpoints were all-cause death and the composite of death and/or HF re-admission within 1 year. Cox regression analysis was used to evaluate the association between digoxin treatment and prognosis. Results: 401 patients received digoxin treatment; of these, 86% had atrial fibrillation. The mean baseline heart rate was 86 ± 22 bpm. At the 1-year follow-up, 375 patients (20.5%) died and 684 (37.3%) presented composite endpoints. Patients treated with digoxin showed higher rates of death (3.21 vs. 2.44 per 10 person-years, p = .019) and composite endpoint (6.72 vs. 5.18 per 10 person-years, p = .003). After multivariate adjustment, digoxin treatment remained associated with increased risks of death (HR = 1.46, 95% CI: 1.16–1.85, p = .001) and the composite endpoint (HR = 1.35, 95% CI: 1.13–1.61, p = .001). A distinctive prognostic effect of digoxin was found across the heart rate continuum; the risks for both endpoints were higher at lower heart rates and neutral at higher heart rates (p of the interactions = 0.007 and 0.03, respectively). Conclusions: In older patients with HFpEF discharged after AHF, digoxin treatment was associated with increased mortality and/or re-admission, particularly in patients with lower heart rates.
URI: http://hdl.handle.net/10553/70652
ISSN: 0953-6205
DOI: 10.1016/j.ejim.2018.10.010
Source: European Journal of Internal Medicine [ISSN 0953-6205], n. 60, p. 18-23
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

5
checked on May 9, 2021

Page view(s)

46
checked on May 11, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.